Cognition as an Outcome Measure in Schizophrenia by Srivastava, Amresh
Western University
Scholarship@Western
Psychiatry Presentations Psychiatry Department
2007
Cognition as an Outcome Measure in
Schizophrenia
Amresh Srivastava
University of Western Ontario, amresh.srivastava@sjhc.london.on.ca
Follow this and additional works at: https://ir.lib.uwo.ca/psychiatrypres
Part of the Neurosciences Commons, and the Psychiatry and Psychology Commons
Citation of this paper:
Srivastava, Amresh, "Cognition as an Outcome Measure in Schizophrenia" (2007). Psychiatry Presentations. 3.
https://ir.lib.uwo.ca/psychiatrypres/3
Cognition as an outcome
measure in schizophrenia
Amresh Srivastava
UWO
RHMC-St.Thomas
Kraepelin adopted the term dementia
praecox to level a condition characterized
by early psychosis and cognitive
deterioration
! Bluer though emphasized on affect thought
and perception, still viewed cognitive deficit
as integral to disorder
The perceived importance of
cognition in schizophrenia has since
waxed and waned.
! Kraeplins cognitive and negative symptoms
were overshadowed by more observable
symptoms like positive symptoms
! RDC DSM iii and iv all emphasized on
positive symptoms and cognition is still not
included in the criteria.
A renewed interest in cognition
was seen recently  Spurred by
strong empirical relationship
between cognition and real world
functioning.
Several studies have failed to
demonstrate positive
correlation between positive
symptoms and functioning
Impaired cognition as core
feature of schizophrenia
! Severely impaired performance on cognitive tests
! One to 2 SD below normal ,in metaanalysis,
! Broad cognitive deficit of moderate to severe
magnitude
! Cognitive symptoms lack correlation with positive
symptoms and severity.
Impaired cognition is not an
epiphenomenon of clinical
symptom.
! Some studies have reported normal
cognition in significant number of people.
! 80-95% of twins with schizophrenia scored
scored below their unaffected twins.
98% of people with schizophrenia
performed below the level
predicted by estimates of their
premorbid functioning as against
42% controls,based on a 
meta-analysis
Several studies have now
demonstrated that cognitive
deficits occurs in first episode
schizophrenia who have never
taken antipsychotics
Unlike Schneider's first rank
symptoms cognitive symptoms
correlate highly with measures of
functional outcome
Cognitive factors are key and
perhaps limiting factors in
rehabilitation.
! Overwhelming evidence of cognitive deficit
has spurred USA NIMH to target such
deficits by pharmacological interventions
Separate domain of deficit vs.
general deficit
! Deficit is best described as broad and  in specific
domains
! A large meta-analysis found that performance is
best described on six domains of cognition
! Verbal comprehension; perceptual organization
! Auditory memory; visual memory
! Working memory & processing speed
Some analysis described strikingly broad
deficit spanning all domains; others found
deficit on specific domains e.g working
memory,executive function, & verbal memory,
! Though some have found differential impairment
across domains,
! others have noted that the impairment is
mediated through a final common factor,
! suggesting ‘generalized cognitive impairment’
This debate has implication for
etiology:
whether underlying brain
abnormalities are local or global.
Tools for measuring Cognition
! Depends upon the research question
! Large batteries have disadvantage of
missing data
! Extensive batteries are impractical
! However a larger battery increases the
chances of measuring multiple domains of
cognition.
Test batteries
! WAIS-III; WMS-III- lengthy,
! MCCB: many domain scores on performance
! Scores: high face validity, high subjectivity
! UPSA: domain level analysis not possible
! RBANS: lacks measures of domains
! BACS: minimum time required, designed for
research
! BCA: High correlation with functional outcome
! Computerized batteries
! Psycho physiological tests
Cognitive impairment is returning
to prominence
! Being considered for inclusion in ICD &
DSM.
! Most cognitive outcomes measures tend to
suffer from low face validity
! It is not obvious to patient /caregivers that
improvement in cognition would make  a
difference to patients quality of life.
! Thus appropriate test for functional
outcome needs to be co-administered

